Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 15:50:42 UTC
Update Date2021-09-26 23:11:06 UTC
HMDB IDHMDB0255887
Secondary Accession NumbersNone
Metabolite Identification
Common NameOclacitinib
DescriptionN-methyl-1-{4-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclohexyl}methanesulfonamide belongs to the class of organic compounds known as pyrrolo[2,3-d]pyrimidines. These are aromatic heteropolycyclic compounds containing a pyrrolo[2,3-d]pyrimidine ring system, which is an pyrrolopyrimidine isomers having the 3 ring nitrogen atoms at the 1-, 5-, and 7-positions. N-methyl-1-{4-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclohexyl}methanesulfonamide is a drug. Based on a literature review very few articles have been published on N-methyl-1-{4-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclohexyl}methanesulfonamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Oclacitinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Oclacitinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-Methyl-1-{4-[methyl({7h-pyrrolo[2,3-D]pyrimidin-4-yl})amino]cyclohexyl}methanesulphonamideGenerator
ApoquelMeSH
OclacitinibMeSH
Chemical FormulaC15H23N5O2S
Average Molecular Weight337.44
Monoisotopic Molecular Weight337.157246175
IUPAC NameN-methyl-1-{4-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclohexyl}methanesulfonamide
Traditional NameN-methyl-1-{4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methanesulfonamide
CAS Registry NumberNot Available
SMILES
CNS(=O)(=O)CC1CCC(CC1)N(C)C1=NC=NC2=C1C=CN2
InChI Identifier
InChI=1S/C15H23N5O2S/c1-16-23(21,22)9-11-3-5-12(6-4-11)20(2)15-13-7-8-17-14(13)18-10-19-15/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,17,18,19)
InChI KeyHJWLJNBZVZDLAQ-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pyrrolo[2,3-d]pyrimidines. These are aromatic heteropolycyclic compounds containing a pyrrolo[2,3-d]pyrimidine ring system, which is an pyrrolopyrimidine isomers having the 3 ring nitrogen atoms at the 1-, 5-, and 7-positions.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyrrolopyrimidines
Sub ClassPyrrolo[2,3-d]pyrimidines
Direct ParentPyrrolo[2,3-d]pyrimidines
Alternative Parents
Substituents
  • Pyrrolo[2,3-d]pyrimidine
  • Dialkylarylamine
  • Aminopyrimidine
  • Pyrimidine
  • Organic sulfonic acid amide
  • Organosulfonic acid amide
  • Imidolactam
  • Pyrrole
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Sulfonyl
  • Aminosulfonyl compound
  • Heteroaromatic compound
  • Azacycle
  • Organonitrogen compound
  • Organopnictogen compound
  • Organic oxide
  • Organosulfur compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.25ALOGPS
logP1.31ChemAxon
logS-3.3ALOGPS
pKa (Strongest Acidic)11.25ChemAxon
pKa (Strongest Basic)7.16ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area90.98 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity90.74 m³·mol⁻¹ChemAxon
Polarizability35.48 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+170.22830932474
DeepCCS[M-H]-167.8730932474
DeepCCS[M-2H]-201.35330932474
DeepCCS[M+Na]+176.5830932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 20229.7648 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.17 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1533.1 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid179.2 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid118.0 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid161.0 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid102.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid290.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid312.6 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)714.0 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid675.1 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid75.2 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid775.3 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid177.6 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid231.4 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate688.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA495.9 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water112.3 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
OclacitinibCNS(=O)(=O)CC1CCC(CC1)N(C)C1=NC=NC2=C1C=CN24657.1Standard polar33892256
OclacitinibCNS(=O)(=O)CC1CCC(CC1)N(C)C1=NC=NC2=C1C=CN23234.1Standard non polar33892256
OclacitinibCNS(=O)(=O)CC1CCC(CC1)N(C)C1=NC=NC2=C1C=CN23264.5Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Oclacitinib,1TMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC13110.4Semi standard non polar33892256
Oclacitinib,1TMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC12895.3Standard non polar33892256
Oclacitinib,1TMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC14440.5Standard polar33892256
Oclacitinib,1TMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C)CC13140.0Semi standard non polar33892256
Oclacitinib,1TMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C)CC12895.6Standard non polar33892256
Oclacitinib,1TMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C)CC14585.8Standard polar33892256
Oclacitinib,2TMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC13081.8Semi standard non polar33892256
Oclacitinib,2TMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC13075.4Standard non polar33892256
Oclacitinib,2TMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C)CC14179.6Standard polar33892256
Oclacitinib,1TBDMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC13333.6Semi standard non polar33892256
Oclacitinib,1TBDMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC13180.0Standard non polar33892256
Oclacitinib,1TBDMS,isomer #1CN(C1=NC=NC2=C1C=C[NH]2)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC14463.1Standard polar33892256
Oclacitinib,1TBDMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C(C)(C)C)CC13327.9Semi standard non polar33892256
Oclacitinib,1TBDMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C(C)(C)C)CC13164.6Standard non polar33892256
Oclacitinib,1TBDMS,isomer #2CNS(=O)(=O)CC1CCC(N(C)C2=NC=NC3=C2C=CN3[Si](C)(C)C(C)(C)C)CC14576.0Standard polar33892256
Oclacitinib,2TBDMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C(C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC13501.0Semi standard non polar33892256
Oclacitinib,2TBDMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C(C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC13602.0Standard non polar33892256
Oclacitinib,2TBDMS,isomer #1CN(C1=NC=NC2=C1C=CN2[Si](C)(C)C(C)(C)C)C1CCC(CS(=O)(=O)N(C)[Si](C)(C)C(C)(C)C)CC14179.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Oclacitinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-003f-7892000000-2006b44e88dfc50eb5c02021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Oclacitinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 10V, Positive-QTOFsplash10-0079-0009000000-9f4da786ab209e541a722017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 20V, Positive-QTOFsplash10-052f-1496000000-b6e464932f836e0bba9e2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 40V, Positive-QTOFsplash10-014i-3920000000-33794b4b3669c21a8a062017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 10V, Negative-QTOFsplash10-000i-3009000000-5950bf020625aace36bb2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 20V, Negative-QTOFsplash10-056u-9247000000-dc480444a102865b2cad2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Oclacitinib 40V, Negative-QTOFsplash10-01r7-9620000000-c98964d0f66d8338e52a2017-07-26Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11441
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID35143246
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound44631938
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]